Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate

O'Mahony, Alison, John, Markus R., Cho, Hannah, Hashizume, Misato and Choy, Ernest H. ORCID: https://orcid.org/0000-0003-4459-8609 2018. Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate. Journal of Translational Medicine 16 , 156. 10.1186/s12967-018-1532-5

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (3MB) | Preview

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Publisher:	BioMed Central
ISSN:	1479-5876
Date of First Compliant Deposit:	19 June 2018
Date of Acceptance:	30 May 2018
Last Modified:	11 Oct 2023 22:07
URI:	https://orca.cardiff.ac.uk/id/eprint/112560

Citation Data

Cited 6 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item